Literature DB >> 2456242

The glycoprotein hormones: recent studies of structure-function relationships.

R J Ryan1, M C Charlesworth, D J McCormick, R P Milius, H T Keutmann.   

Abstract

The structural features of the heterodimeric glycoprotein hormones (LH, FSH, TSH, and hCG) are briefly reviewed. Removal of carbohydrate chains does not reduce binding of the hormones to membrane receptors, but markedly reduces biological responses. The glycopeptides from the hormone do not reduce binding of native hormone to receptors but do reduce biological responses. Newer data concerned with replication of different regions of the peptide chains of these molecules using synthetic peptides are reviewed and presented. These studies indicate that two regions on the common alpha subunit are involved with receptor binding of the LH, hCG, and TSH molecules. These regions are alpha 26 to 46 and alpha 75-92. Two synthetic disulfide loop peptides from the hCG beta subunit beta 38-57 and beta 93-100 also block binding of hCG to its receptor. In addition, the beta 38-57 peptide stimulates testosterone production by Leydig cells. These data indicate that glycoprotein hormone binding to plasma membrane receptors involves a discontinuous site on the hormone that spans both the alpha and beta subunits, and that the alpha subunit sites are similar for several hormones.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456242     DOI: 10.1096/fasebj.2.11.2456242

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

Review 1.  Molecular structures of glycoprotein hormones and functions of their carbohydrate components.

Authors:  A Stockell Hartree; A G Renwick
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

2.  Synthetic peptides based upon a three-dimensional model for the receptor recognition site of follicle-stimulating hormone exhibit antagonistic or agonistic activity at low concentrations.

Authors:  M Hage-van Noort; W C Puijk; H H Plasman; D Kuperus; W M Schaaper; N J Beekman; J A Grootegoed; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Studies on buffalo pituitary lutropin (LH): physicochemical and immunological properties.

Authors:  T R Kumar; V Prakash; K Muralidhar
Journal:  J Protein Chem       Date:  1990-12

4.  Expression of two forms of carp gonadotropin alpha subunit in insect cells by recombinant baculovirus.

Authors:  C J Huang; F L Huang; G D Chang; Y S Chang; C F Lo; M J Fraser; T B Lo
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

5.  Solid phase synthesis of the fibronectin glycopeptide V(Gal beta 3GalNAc alpha)THPGY, its beta analogue, and the corresponding unglycosylated peptide.

Authors:  B Lüning; T Norberg; C Rivera-Baeza; J Tejbrant
Journal:  Glycoconj J       Date:  1991-12       Impact factor: 2.916

Review 6.  Glycosylation of pituitary hormones: a necessary and multistep control of biopotency.

Authors:  C Ronin
Journal:  Glycoconj J       Date:  1992-12       Impact factor: 2.916

7.  Circular dichroic spectroscopy of Arg46-nicked ovine lutropin alpha and derived fragments.

Authors:  K C Peng; G R Bousfield; D Puett; D N Ward
Journal:  J Protein Chem       Date:  1996-08

8.  Absence of TGF-β Receptor Activation by Highly Purified hCG Preparations.

Authors:  Hannu Koistinen; Laura Hautala; Katri Koli; Ulf-Håkan Stenman
Journal:  Mol Endocrinol       Date:  2015-10-23

9.  Effect of amino group modification of ovine luteinizing hormone (oLH) by N-succinimidyl 6-[3-(2-pyridyldithio)propionate]hexanoate, a long chain N-succinimidyl-3-(2-pyridyldithio) propionate (SPDP) on immunological and biological properties: a comparative study with SPDP modified oLH.

Authors:  V Singh; R Curtiss
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

10.  Measurement of cAMP accumulation in Chinese hamster ovary cells transfected with the recombinant human TSH receptor (CHO-R): a new bioassay for human thyrotropin.

Authors:  L Persani; M Tonacchera; P Beck-Peccoz; P Vitti; C Mammoli; L Chiovato; R Elisei; G Faglia; M Ludgate; G Vassart
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.